Compare SMSI & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMSI | BNGO |
|---|---|---|
| Founded | 1982 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1M | 11.6M |
| IPO Year | 2017 | 2018 |
| Metric | SMSI | BNGO |
|---|---|---|
| Price | $0.78 | $1.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | ★ 344.6K | 86.7K |
| Earning Date | 03-04-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.94 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $17,363,000.00 | $12,000,735.00 |
| Revenue This Year | $61.84 | N/A |
| Revenue Next Year | $58.62 | $24.27 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 26.26 |
| 52 Week Low | $0.41 | $1.06 |
| 52 Week High | $1.30 | $5.50 |
| Indicator | SMSI | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 60.97 | 40.45 |
| Support Level | $0.67 | $1.07 |
| Resistance Level | $0.82 | $1.18 |
| Average True Range (ATR) | 0.08 | 0.04 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 76.00 | 40.00 |
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.